Anybody buying RARX that day and holding through the close because they really thought the deal was scheduled to close on March 30 was right for the wrong reason. There was no scheduled close date, just an announcement from RARX of when the antitrust waiting period was to expire if no action from the FTC.
Fortunately for buyers last month, there was no further extension to the review as was the case the last two times RARX and the acquirer had filed for approval.
News 
Market Data 
Discover 
